Salmeterol Xinafoate

CHEMBL1082607 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

603.7 g/mol

LogP

—

Phase

4

A xinafoate salt form of salmeterol with the same therapeutic properties. A long-acting bronchodilator taken twice daily to keep the airways open and prevent breathing symptoms in asthma and COPD.

Peso Molecular

603,7000 g/mol

TPSA

139,00 Å²

Áreas Terapêuticas

Respiratory Disease Asthma Chronic Obstructive Pulmonary Disease Obesity Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O

InChI

InChI=1S/C25H37NO4.C11H8O3/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21;12-10-8-4-2-1-3-7(8)5-6-9(10)11(13)14/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2;1-6,12H,(H,13,14)

Molecular Formula

C36H45NO7

HBD / HBA

6 / 8

Ligações Rotacionáveis

17

Átomos Pesados

44

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A xinafoate salt form of salmeterol with the same therapeutic properties. A long-acting bronchodilator taken twice daily to keep the airways open and prevent breathing symptoms in asthma and COPD.

Yes, Salmeterol Xinafoate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1082607. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 56801. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Salmeterol Xinafoate no PillFYI

Estrutura

Dados Rápidos

Fórmula: C36H45NO7
Sinônimos: 3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.